Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3784911 Target Snapshot

Receptor-interacting serine/threonine-protein kinase 1 · SINGLE PROTEIN · Mus musculus

68Compounds
26Assays
0Approved Drugs
116.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q60855. Use UniProt Q60855 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q60855 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Receptor-interacting serine/threonine-protein kinase 1 as ChEMBL target CHEMBL3784911, mapped to UniProt Q60855. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Receptor-interacting serine/threonine-protein kinase 1
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3784911
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q60855
Receptor-interacting serine/threonine-protein kinase 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Receptor-interacting serine/threonine-protein kinase 1 is the right protein anchor across sources, using UniProt Q60855 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReceptor-interacting serine/threonine-protein kinase 1
UniProt AccessionQ60855
Component TypeProtein
Sequence Length656 aa

Receptor-interacting serine/threonine-protein kinase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Receptor-interacting serine/threonine-protein kinase 1, mapped to UniProt Q60855. Sequence length is 656 aa.

Mapped IDQ60855
Review nameReceptor-interacting serine/threonine-protein kinase 1
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

2
Phase II
Assay Mix

Activity Type Distribution

IC50113.0
KI2.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4100398 8.57 IC50 2.7 Preclinical
CHEMBL4545939 8.49 IC50 3.2 Preclinical
CHEMBL4092421 7.57 EC50 27.0 Preclinical
CHEMBL4514271 7.5 IC50 32.0 Preclinical
CHEMBL3109202 7.3 IC50 50.0 Preclinical
CHEMBL4100398 7.09 Ki 81.28 Preclinical
CHEMBL4549667 7.0 IC50 100.0 Preclinical
CHEMBL3785703 6.96 IC50 110.0 Preclinical
CHEMBL4445751 6.96 IC50 110.0 Preclinical
CHEMBL4455611 6.72 Ki 189.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
18
5.5
17
6.0
4
6.5
3
7.0
2
7.5
1
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

26
Total Assays
34
Tested Compounds
1
Assay Types
Binding — 26 assays, 34 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 20 26 6.2
single protein format 5 7 6.4
assay format 1 1 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine